HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jamil A Abbasi Selected Research

gimsilumab

1/2022Anti-Granulocyte-Macrophage Colony-Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-controlled Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jamil A Abbasi Research Topics

Disease

1Hypoxia (Hypoxemia)
01/2022
1Pneumonia (Pneumonitis)
01/2022
1COVID-19
01/2022
1Inflammation (Inflammations)
01/2022
1Prostatic Neoplasms (Prostate Cancer)
09/2003
1Blau syndrome
06/2002
1Granuloma
06/2002

Drug/Important Bio-Agent (IBA)

1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2022
1gimsilumabIBA
01/2022
1Monoclonal AntibodiesIBA
01/2022
1ZincIBA
09/2003
1CytokinesIBA
06/2002
1Interleukin-2 (IL2)IBA
06/2002

Therapy/Procedure

1Therapeutics
01/2022